(Q34615729)

3 August 2017

1 reference

title

N-3 fatty acids, cancer and cachexia: a systematic review of the literature (English)

1 reference

3 August 2017

0 references

1 reference

Ramón Colomer

1

1 reference

3 August 2017

José M Moreno-Nogueira

2

1 reference

3 August 2017

Pedro P García-Luna

3

1 reference

3 August 2017

Pilar García-Peris

4

1 reference

3 August 2017

Abelardo García-de-Lorenzo

5

1 reference

3 August 2017

Antonio Zarazaga

6

1 reference

3 August 2017

Luis Quecedo

7

1 reference

3 August 2017

Juan del Llano

8

1 reference

3 August 2017

Luis Usán

9

1 reference

3 August 2017

César Casimiro

10

1 reference

3 August 2017

publication date

1 May 2007

1 reference

British Journal of Nutrition

3 August 2017

published in

1 reference

3 August 2017

volume

97

1 reference

3 August 2017

issue

5

1 reference

3 August 2017

page(s)

823-831

1 reference

Plasma fatty acid levels in autistic children

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Modulation of human immune and inflammatory responses by dietary fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Phase II study of high-dose fish oil capsules for patients with cancer-related cachexia.

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

n-3 polyunsaturated fatty acids and colon cancer prevention

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Effect of a protein and energy dense N-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Early enteral feeding in postsurgical cancer patients. Fish oil structured lipid-based polymeric formula versus a standard polymeric formula

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Effect of a fish oil structured lipid-based diet on prostaglandin release from mononuclear cells in cancer patients after surgery

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Effect of a fish oil-enriched nutritional supplement on metabolic mediators in patients with pancreatic cancer cachexia.

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Decreased n-6/n-3 fatty acid ratio reduces the invasive potential of human lung cancer cells by downregulation of cell adhesion/invasion-related genes

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

The importance of outcomes research in documenting the benefit of nutrition intervention

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Eicosapentaenoic acid ethyl ester supplementation in cachectic cancer patients and healthy subjects: effects on lipolysis and lipid oxidation.

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer

1 reference

https://api.crossref.org/works/10.1017%2FS000711450765795X

7 January 2021

10.1017/S000711450765795X

Identifiers

DOI

1 reference

3 August 2017

1 reference